Molecular dynamics simulations provide insights into the origin of gleevec’s selectivity toward human tyrosine kinases

References

• Agafonov, R. V., Wilson, C., Otten, R., Buosi, V., & Kern, D. (2014). Energetic dissection of Gleevec's selectivity toward human tyrosine kinases. Nature Structural & Molecular Biology, 21(10), 848–853.
   PubMed Web of Science ®Google Scholar
• Aleksandrov, A., & Simonson, T. (2010). Molecular dynamics simulations show that conformational selection governs the binding preferences of imatinib for several tyrosine kinases. Journal of Biological Chemistry, 285(18), 13807–13815.
   PubMed Web of Science ®Google Scholar
• Azam, M., Nardi, V., Shakespeare, W. C., Metcalf, C. A., Bohacek, R. S., Wang, Y., … Bornmann, W. G. (2006). Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance. Proceedings of the National Academy of Sciences, 103(24), 9244–9249.
   PubMed Web of Science ®Google Scholar
• Capdeville, R., Buchdunger, E., Zimmermann, J., & Matter, A. (2002). Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nature Reviews Drug Discovery, 1(7), 493–502.
   PubMed Web of Science ®Google Scholar
• Case, D., Darden, T., Cheatham, T., III, Simmerling, C., Wang, J., Duke, R., … Merz, K. (2012). AMBER 12. San Francisco: University of California.
   Google Scholar
• Chatterjee, A., & Datta, P. P. (2017). Intrisinc GTPase activity of a ribosomal maturation protein CgtA is assocaited with its inter-domain movement: Insights into from MD simulations and biochemical studies. Journal of Biomolecular Structure and Dynamics, 35(12), 2578–2587.
   PubMed Web of Science ®Google Scholar
• Chen, F., Liu, H., Sun, H., Pan, P., Li, Y., Li, D., & Hou, T. (2016). Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking. Physical Chemistry Chemical Physics, 18(32), 22129–22139.
   PubMed Web of Science ®Google Scholar
• Cowan-Jacob, S. W., Fendrich, G., Manley, P. W., Jahnke, W., Fabbro, D., Liebetanz, J., & Meyer, T. (2005). The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Structure, 13(6), 861–871.
   PubMed Web of Science ®Google Scholar
• Dar, A. C., Lopez, M. S., & Shokat, K. M. (2008). Small molecule recognition of c-Src via the Imatinib-binding conformation. Chemistry & Biology, 15(10), 1015–1022.
   PubMedGoogle Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092.
   Web of Science ®Google Scholar
• Duan, Y., Wu, C., Chowdhury, S., Lee, M. C., Xiong, G., Zhang, W., … Kollman, P. (2003). A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Journal of Computational Chemistry, 24(16), 1999–2012.
   PubMed Web of Science ®Google Scholar
• Fiser, A., & Sali, A. (2003). Modeller: Generation and refinement of homology-based protein structure models. Methods in Enzymology, 374, 461–491.
   PubMed Web of Science ®Google Scholar
• Frisch, M., Trucks, G., Schlegel, H., Scuseria, G., Robb, M., Cheeseman, J. Parr. (2009). Gaussian 09, revision A. 02. Wallingford, CT: Gaussian, Inc.
   Google Scholar
• Glykos, N. M. (2006). Software news and updates carma: A molecular dynamics analysis program. Journal of Computational Chemistry, 27(14), 1765–1768.
   PubMed Web of Science ®Google Scholar
• Guimaraes, C. R., Rai, B. K., Munchhof, M. J., Liu, S., Wang, J., Bhattacharya, S. K., & Buckbinder, L. (2011). Understanding the impact of the P-loop conformation on kinase selectivity. Journal of Chemical Information and Modeling, 51(6), 1199–1204.
   PubMed Web of Science ®Google Scholar
• Hertig, S., Latorraca, N. R., & Dror, R. O. (2016). Revealing atomic-level mechanisms of protein allostery with molecular dynamics simulations. PLoS Computational Biology, 12(6), e1004746.
   PubMed Web of Science ®Google Scholar
• Hou, T., Li, N., Li, Y., & Wang, W. (2012). Characterization of domain-peptide interaction interface: Prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models. Journal of Proteome Research, 11(5), 2982–2995.
   PubMed Web of Science ®Google Scholar
• Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38.
   PubMedGoogle Scholar
• Huse, M., & Kuriyan, J. (2002). The conformational plasticity of protein kinases. Cell, 109(3), 275–282.
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935.
   Web of Science ®Google Scholar
• Levinson, N. M., Kuchment, O., Shen, K., Young, M. A., Koldobskiy, M., Karplus, M., … Kuriyan, J. (2006). A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biology, 4(5), e144
   PubMed Web of Science ®Google Scholar
• Levitzki, A. (2003). Protein kinase inhibitors as a therapeutic modality. Accounts of Chemical Research, 36(6), 462–469.
   PubMed Web of Science ®Google Scholar
• Lin, Y. L., Meng, Y., Jiang, W., & Roux, B. (2013). Explaining why Gleevec is a specific and potent inhibitor of Abl kinase. Proceedings of the National Academy of Sciences of the United States of America, 110(5), 1664–1669.
   PubMed Web of Science ®Google Scholar
• Lovera, S., Sutto, L., Boubeva, R., Scapozza, L., Dolker, N., & Gervasio, F. L. (2012). The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation. Journal of the American Chemical Society, 134(5), 2496–2499.
   PubMed Web of Science ®Google Scholar
• Lu, S., Deng, R., Jiang, H., Song, H., Li, S., Shen, Q., … Zhang, J. (2015). The Mechanism of ATP-dependent allosteric protection of Akt kinase phosphorylation. Structure, 23(9), 1725–1734.
   PubMed Web of Science ®Google Scholar
• Lu, S., Huang, W., Wang, Q., Shen, Q., Li, S., Nussinov, R., & Zhang, J. (2014). The structural basis of ATP as an allosteric modulator. PLoS Computational Biology, 10(9), e1003831
   PubMed Web of Science ®Google Scholar
• Lu, S., Jang, H., Gu, S., Zhang, J., & Nussinov, R. (2016a). Drugging Ras GTPase: A comprehensive mechanistic and signaling structural view. Chemical Society Reviews, 45(18), 4929–4952.
   PubMed Web of Science ®Google Scholar
• Lu, S., Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., Nussinov, R., & Zhang, J. (2016b). Ras conformational ensembles, allostery, and signaling. Chemical Reviews, 116(11), 6607–6665.
   PubMed Web of Science ®Google Scholar
• Lu, S., Ji, M., Ni, D., & Zhang, J. (2018). Discovery of hidden allosteric sites as novel targets for allosteric drug design. Drug Discovery Today, 23(2), 359–365.
   PubMed Web of Science ®Google Scholar
• Lu, S., Li, S., & Zhang, J. (2014). Harnessing allostery: A novel approach to drug discovery. Med Res Rev, 34(6), 1242–1285.
   PubMed Web of Science ®Google Scholar
• Lu, S., & Zhang, J. (2017). Designed covalent allosteric modulators: An emerging paradigm in drug discovery. Drug Discovery Today, 22(2), 447–453.
   PubMed Web of Science ®Google Scholar
• Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science, 298(5600), 1912–1934.
   PubMed Web of Science ®Google Scholar
• Matthews, D. J., & Gerritsen, M. E. (2011). Targeting protein kinases for cancer therapy, John Wiley & Sons.ISBN 978-1-118-21077-2.
   Google Scholar
• Mou, L., Cui, T., Liu, W., Zhang, H., Cai, Z., Lu, S., & Gao, G. (2017). Microsecond molecualr dynamics simulations provide insight into the ATP-competitive inhibitor-induced allosteric protection of Akt kinase phorphoeylation. Chemical Biology & Drug Design, 89(5), 723–731.
   PubMed Web of Science ®Google Scholar
• Nagar, B., Bornmann, W. G., Pellicena, P., Schindler, T., Veach, D. R., Miller, W. T., … Kuriyan, J. (2002). Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571. ). Cancer Research, 62, 4236–4243.
   PubMed Web of Science ®Google Scholar
• Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, W., … Kuriyan, J. (2003). Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell, 112(6), 859–871.
   PubMed Web of Science ®Google Scholar
• Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341.
   Web of Science ®Google Scholar
• Sanjeev, A., Sahu, R. K., & Mattaparthi, V. S. K. (2017). Potential of mean force and molecular dynamics study on the transient interactions between α and β synuclein that drive inhibition of α-synuclein aggregation. Journal of Biomolecular Structure and Dynamics, 35(15), 3342–3353.
   PubMed Web of Science ®Google Scholar
• Saraste, M., Sibbald, P. R., & Wittinghofer, A. (1990). The P-loop-a common motif in ATP- and GTP-binding proteins. Trends in Biochemical Sciences, 15(11), 430–434.
   PubMed Web of Science ®Google Scholar
• Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000). Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science, 289(5486), 1938–1942.
   PubMed Web of Science ®Google Scholar
• Sciabola, S., Stanton, R. V., Wittkopp, S., Wildman, S., Moshinsky, D., Potluri, S., & Xi, H. (2008). Predicting kinase selectivity profiles using Free-Wilson QSAR analysis. Journal of Chemical Information and Modeling, 48(9), 1851–1867.
   PubMed Web of Science ®Google Scholar
• Seeliger, M. A., Nagar, B., Frank, F., Cao, X., Henderson, M. N., & Kuriyan, J. (2007). c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. Structure, 15(3), 299–311.
   PubMed Web of Science ®Google Scholar
• Sun, H., Li, Y., Shen, M., Tian, S., Xu, L., Pan, P., … Hou, T. (2014). Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. Physical Chemistry Chemical Physics, 16(40), 22035–22045.
   PubMed Web of Science ®Google Scholar
• Sun, H., Li, Y., Tian, S., Xu, L., & Hou, T. (2014). Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Physical Chemistry Chemical Physics, 16(31), 16719–16729.
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Zhu, G.-F., Ren, S.-Y., Han, Y.-G., Luo, Y., & Du, L.-F. (2013). Insight into the structural stability of wild type and mutants of the tobacco etch virus protease with molecular dynamics simulations. Journal of Molecular Modeling, 19, 4865–4875.
   PubMed Web of Science ®Google Scholar
• Wenqing, W., Harrison, S. C., & Eck, M. J. (1997). Three-dimensional structure of the tyrosine kinase c-Src. Nature, 385(6617), 595–602.
   PubMed Web of Science ®Google Scholar
• Williams, J. C., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S. A., Superti-Furga, G., & Wierenga, R. K. (1997). The 2.35 Å crystal structure of the inactivated form of chicken Src: A dynamic molecule with multiple regulatory interactions. Journal of Molecular Biology, 274(5), 757–775.
   PubMed Web of Science ®Google Scholar
• Wilson, C., Agafonov, R. V., Hoemberger, M., Kutter, S., Zorba, A., Halpin, J., … Kern, D. (2015). Kinase dynamics. Using ancient protein kinases to unravel a modern cancer drug's mechanism. Science, 347(6224), 882–886.
   PubMed Web of Science ®Google Scholar
• Winter, G. E., Rix, U., Carlson, S. M., Gleixner, K. V., Grebien, F., Gridling, M., … Colinge, J. (2012). Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. Nature Chemical Biology, 8(11), 905–912.
   PubMed Web of Science ®Google Scholar
• Wu, X., & Brooks, B. R. (2003). Self-guided Langevin dynamics simulation method. Chemical Physics Letters, 381(3-4), 512–518.
   Web of Science ®Google Scholar
• Xu, W., Doshi, A., Lei, M., Eck, M. J., & Harrison, S. C. (1999). Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Molecular Cell, 3(5), 629–638.
   PubMed Web of Science ®Google Scholar
• Xu, L., Sun, H., Li, Y., Wang, J., & Hou, T. (2013). Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. The Journal of Physical Chemistry. B, 117(28), 8408–8421.
   PubMed Web of Science ®Google Scholar
• Yang, Y., Shen, Y., Liu, H., & Yao, X. (2011). Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38α MAP kinase. Journal of Chemical Information and Modeling, 51(12), 3235–3246.
   PubMed Web of Science ®Google Scholar
• Zhu, J., Li, X., Zhang, S., Ye, H., Zhao, H., Jin, H., & Han, W. (2017). Exploring stereochemical specificity of phosphotriesterase by MM-PBSA and MM-GBSA calculation and steered molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 35(14), 3140–3151.
   PubMed Web of Science ®Google Scholar